MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
10.88
-0.95 (-8.03%)
Feb 21, 2025, 4:00 PM EST - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $363.58 million as of February 21, 2025.
Market Cap
363.58M
Enterprise Value
86.73M
1-Year Change
n/a
Ranking
Category
Stock Price
10.88
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $363.58M, a decrease of -28.66%. That is a compound annual growth rate of -53.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 395.33M | -35.81% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |